J. Martin Carroll

Companies

• Esperion TherapeuticsBoard member Jun 1, 2022 to now¹
• Catalent Pharma SolutionsBoard member Jul 30, 2015 to Dec 18, 2024²
• Keenova Therapeutics plcBoard member Jul 2, 2013 to Jun 21, 2022³
• TherapeuticsMD, Inc.Board member Mar 26, 2015 to Aug 12, 2021⁴
• Rocket Pharmaceuticals Inc.Board member Apr 4, 2016 to Jun 21, 2017⁵
• VivusBoard member May 13, 2013 to Aug 16, 2013⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEsperion Therapeutics ESPR0 shares⁷Jul 13, 2026
• Catalent Pharma Solutions CTLT11,663 shares⁸Dec 18, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 13, 2026Returned to company 177,523 shares of Esperion Therapeutics⁷
• May 28, 2026Granted 79,873 shares of Esperion Therapeutics⁹
• May 29, 2025Granted 33,000 shares of Esperion Therapeutics¹⁰
• Dec 18, 2024Returned to company 32,734 shares of Catalent Pharma Solutions⁸
• Oct 30, 2024Granted 4,663 shares of Catalent Pharma Solutions¹¹
• May 23, 2024Granted 23,000 shares of Esperion Therapeutics¹²
• Oct 27, 2023Granted 6,993 shares of Catalent Pharma Solutions¹³
• Jul 1, 2023Granted 555 shares of Catalent Pharma Solutions¹⁴
• Jun 15, 2023Granted 5,150 shares of Esperion Therapeutics¹⁵
• May 11, 2023Bought 23,091 shares at $1.57 of Esperion Therapeutics¹⁶
• May 10, 2023Bought 8,409 shares at $1.49 of Esperion Therapeutics¹⁶
• Oct 27, 2022Granted 4,149 shares of Catalent Pharma Solutions¹⁷
• Jun 2, 2022Bought 5,000 shares at $5.64 of Esperion Therapeutics¹⁸
• Nov 29, 2021Other 3,136 shares at $134.12 of Catalent Pharma Solutions¹⁹
• Nov 29, 2021Other 3,136 shares at $134.12 of Catalent Pharma Solutions¹⁹
• Nov 29, 2021Gift 3,136 shares of Catalent Pharma Solutions¹⁹
• Nov 29, 2021Gift 3,136 shares of Catalent Pharma Solutions¹⁹
• Oct 28, 2021Granted 1,402 shares of Catalent Pharma Solutions²⁰